Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 4.120
-0.030 (-0.72%)
Mar 31, 2026, 3:51 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 210.68 million as of March 31, 2026.
Market Cap
210.68M
Enterprise Value
200.32M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.12
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 210.68M, an increase of 38.60%. That is a compound annual growth rate of 54.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 210.68M | 27.62% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 496.99M |
| Racura Oncology | 464.02M |
| Orthocell | 203.48M |
| Starpharma Holdings | 197.46M |
| Dimerix | 195.13M |
| Recce Pharmaceuticals | 137.36M |
| Actinogen Medical | 125.70M |
| Amplia Therapeutics | 125.70M |